All Stories

  1. Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasis

    Article • Journal of Dermatological Treatment, July 2019, Taylor & Francis

    Alan Menter MD, alan mendelsohn